31st Jul 2017 7:00 am |
RNS |
Disposal of BTK inhibitor drug development program |
23rd Jun 2017 2:38 pm |
RNS |
MHRA approval of Clinical Trial Application |
22nd Jun 2017 7:00 am |
RNS |
Update on Suspension of Trading |
24th May 2017 6:35 pm |
RNS |
Statement re. Suspension |
24th May 2017 4:35 pm |
RNS |
Suspension - Redx Pharma plc |
17th May 2017 7:00 am |
RNS |
Interim results for six months ended 31 March 2017 |
15th May 2017 7:00 am |
RNS |
Preclinical efficacy data presented on RXC005 |
4th May 2017 7:00 am |
RNS |
Notice of Interim Results |
20th Apr 2017 11:20 am |
RNS |
Result of AGM |
20th Apr 2017 7:00 am |
RNS |
Appointment of Chairman |
7th Apr 2017 3:56 pm |
RNS |
Notice of Annual General Meeting |
3rd Apr 2017 7:15 am |
RNS |
Hardman: CARB-X - new strategic collaboration |
30th Mar 2017 4:03 pm |
RNS |
Redx Pharma awarded US$1 million grant by CARB-X |
21st Mar 2017 9:05 am |
RNS |
Final Results Year Ended 30 September 2016 |
7th Mar 2017 4:33 pm |
RNS |
Holding(s) in Company |
3rd Mar 2017 2:35 pm |
RNS |
Holding(s) in Company |
3rd Mar 2017 2:27 pm |
RNS |
Holding(s) in Company |
3rd Mar 2017 2:17 pm |
RNS |
Holding(s) in Company |
2nd Mar 2017 5:01 pm |
RNS |
Holding(s) in Company |
2nd Mar 2017 7:50 am |
RNS |
Redx presentations at AACR 2017 |
28th Feb 2017 10:35 am |
RNS |
Result of General Meeting and Issue of Equity |
27th Feb 2017 5:50 pm |
RNS |
Result of Open Offer |
10th Feb 2017 1:00 pm |
RNS |
Result of Placing |
9th Feb 2017 7:00 am |
RNS |
Accelerated Book Build |
8th Feb 2017 6:30 pm |
RNS |
Accelerated Book Build |
27th Jan 2017 7:00 am |
RNS |
Growing opportunity for Porcupine inhibitors |
6th Dec 2016 7:00 am |
RNS |
Reversible BTK poster at ASH meeting |
30th Nov 2016 7:00 am |
RNS |
RXC004 pre-clinical profile |
16th Nov 2016 3:22 pm |
RNS |
Holding(s) in Company |
4th Nov 2016 7:00 am |
RNS |
Reversible BTK data at ASH meeting |
20th Oct 2016 7:00 am |
RNS |
Development candidate chosen for leukaemia program |
11th Oct 2016 9:32 am |
RNS |
Exercise of Options and Total Voting Rights |
27th Sep 2016 7:00 am |
RNS |
Discovery of breakthrough antibiotic compounds |
23rd Sep 2016 4:07 pm |
RNS |
Holding(s) in Company |
21st Sep 2016 8:50 am |
RNS |
Holding(s) in Company |
19th Sep 2016 7:00 am |
RNS |
Re: Porcupine inhibitor and cancer immunotherapy |
16th Sep 2016 11:31 am |
RNS |
Holding(s) in Company |
14th Sep 2016 10:47 am |
RNS |
Holding(s) in Company |
8th Sep 2016 7:00 am |
RNS |
Board & Senior Management Changes |
6th Sep 2016 7:00 am |
RNS |
Supply agreement for expected clinical trial |